LATOYA GEORGE: Open Payments
NPI 1518739366 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 31 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $232 · 2025 $870
Food & beverage: $870
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $333 |
| Neurocrine BioSciences, Inc. | 12 | $308 |
| Lundbeck LLC | 5 | $124 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Alkermes, Inc. | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: COBENFY, INGREZZA, REXULTI, ABILIFY ASIMTUFII, ARISTADA, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
